We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
Sorry elves, not even the North Pole will be spared by America’s trade war. #PUPPETREGIME
Watch more PUPPET REGIME!
Subscribe to GZERO Media's YouTube channel to get notifications when new videos are published.
Microsoft’s AI for Good Lab, in collaboration with Nobel Prize winner David Baker, Seoul National University Professor Minkyung Baek, MIT Professor Bonnie Berger, and University of Pennsylvania Professor Gregory Bowman, have developed Seq2Symm, an AI model that can predict protein structures 80,000 times faster than previous methods. Understanding these structures is key to breakthroughs in medicine, disease research, and synthetic biology. Seq2Symm’s open-source technology will help scientists accelerate drug discovery, better understand diseases like Alzheimer’s, and develop new bioengineered materials. By making protein research faster and more accessible, Microsoft is helping unlock life’s biggest mysteries.
Learn more here.
